Filed under: Comfort Zone InvestingTed Allrich is the founder of The Online Investor and author of the just released book: Comfort Zone Investing: Build Wealth And Sleep Well At Night. In this weekly column, he'll offer advice to investors who are just getting started.The last two columns described my experience with two biotech stocks. One was bad Hollis-Eden Pharmaceuticals (NASDAQ: HEPH). One was good Dendreon Corp. (NASDAQ: DNDN). (Please note that I am not recommending you buy or sell either of these.) Here's what I learned from the experience of losing a large amount of money, then gaining some of it back.First, I got greedy. As they say on the Street, bulls and bears make money, pigs get slaughtered. I over-leveraged my position in HEPH because I got ...
Filed under: Comfort Zone InvestingTed Allrich is the founder of The Online Investor and author of the just released book: Comfort Zone Investing: Build Wealth And Sleep Well At Night. In this weekly column, he'll offer advice to investors who are just getting started.The last two columns described my experience with two biotech stocks. One was bad Hollis-Eden Pharmaceuticals (NASDAQ: HEPH). One was good Dendreon Corp. (NASDAQ: DNDN). (Please note that I am not recommending you buy or sell either of these.) Here's what I learned from the experience of losing a large amount of money, then gaining some of it back.First, I got greedy. As they say on the Street, bulls and bears make money, pigs get slaughtered. I over-leveraged my position in HEPH because I got ...
Responses to 'Comfort Zone Investing: Biotech tale - epilogue and lessons learned'